Harvard Dana-Farber Cancer Institute’s ASH Highlights 2025

Course Overview

This activity is designed to educate hematologists, oncologists, and other clinicians on new developments in the diagnosis and treatment of all blood cancers. Through disease-specific lectures, highlighting the most clinically relevant data presented at the ASH Annual Meeting, attendees will be able to identify and describe emerging treatments and utilize these advances in their professional practice.

The American Society of Hematology’s annual meeting is the premier venue for unveiling cutting-edge therapeutic advances in hematology. Since only a small fraction of practitioners can attend in person, this one-day activity provides timely access to the latest updates in acute leukemia, myelodysplasia, myeloproliferative disorders, chronic myelogenous leukemia, chronic lymphocytic leukemia, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, multiple myeloma, Waldenstrom’s macroglobulinemia, coagulation disorders, hematopoietic stem cell transplantation, and CAR-T therapies[1][2][3][4][5].

Who Should Attend

• Oncology and Hematology Physicians and Trainees
• Primary Care Physicians
• Nurses
• Physician Assistants
• Nurse Practitioners

Learning Objectives

• Describe and highlight recent medical advances presented at the ASH Annual Meeting to achieve better patient outcomes.
• Recognize appropriate management and treatment options for hematologic malignancies.
• Apply new approaches in routine clinical practice.
• Review new therapies and strategies in non-malignant hematology.

2025 Agenda

Information for the 2026 course is not yet available.

All agenda sessions are in Eastern Time.

• Saturday, February 8, 2025
• • 9:00–9:10 AM: Welcome and Introduction – Ann S. LaCasce, MD
  • 9:10–9:50 AM: ASH 2024: Transplant Highlights – Mahasweta Gooptu, MD
  • 9:50–10:30 AM: ASH 2024: ALL, CML and MPNs Highlights – Daniel DeAngelo, MD, PhD
  • 10:30–11:10 AM: ASH 2024: Classical Hematology Highlights – Nathan T. Connell, MD, MPH
  • 11:10–11:50 AM: ASH 2024: MDS and AML – Richard M. Stone, MD
  • 11:50 AM–12:05 PM: 15-minute Break
  • 12:05–12:45 PM: ASH 2024: CLL Highlights – Inhye E. Ahn, MD
  • 12:45–1:25 PM: ASH 2024: Multiple Myeloma Highlights – Shonali Midha, MD
  • 1:25–2:05 PM: ASH 2024: Lymphoma Highlights – Jennifer L. Crombie, MD
  • 2:05–2:45 PM: ASH 2024: CAR-T Highlights – Caron A. Jacobson, MD
  • 2:45–2:55 PM: Closing Remarks – Ann S. LaCasce, MD